Trazimera 00069-0308
Generic: Trastuzumab-Qyyp
Product NDC
00069-0308- Manufacturer
- Pfizer Laboratories Div Pfizer Inc
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- March 10, 2021
- Listing Expires
- December 31, 2027
- Application
- BLA761081
Need to source Trazimera? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Trastuzumab | 150 mg/7.15mL |
Drug Class
HER2/neu Receptor Antagonist [EPC]HER2/Neu/cerbB2 Antagonists [MoA]HER2/neu Receptor Antagonist [EPC]
Packaging Options(1)
1 VIAL in 1 CARTON (0069-0308-01) / 7.15 mL in 1 VIAL